Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Update on gamma-hydroxybutyric acid].

F B García1, C Pedraza, J F Navarro

  • 1Departamento de Psicología, Facultad de Psicología , Universidad de Malaga, Espana.

Revista De Neurologia
|June 30, 2006
PubMed
Summary

Gamma-hydroxybutyric acid (GHB) acts as a neurotransmitter in the brain and has therapeutic uses, but its potential for abuse and neurotoxicity requires careful consideration.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From juvenile stress to adult depressive-like behavior: A systematic review of biomarkers, developmental timing, and sex differences.

Neuroscience and biobehavioral reviews·2026
Same author

MEYER project: Towards a national protocol for in vivo measurement of <sup>131</sup>I in the thyroid of exposed populations in emergencies.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2026
Same author

Preclinical data and design of a phase I clinical trial of neoantigen-reactive TILs for advanced epithelial or ICB-resistant solid cancers.

Immuno-oncology technology·2025
Same author

The European intercomparison of in-vivo monitoring laboratories: the EIVIC-2020 project.

Radiation and environmental biophysics·2024
Same author

Social avoidance and altered hypothalamic-pituitary-adrenal axis in a mouse model of anxious depression: The role of LPA<sub>1</sub> receptor.

Behavioural brain research·2023
Same author

Deforestation in Colombian protected areas increased during post-conflict periods.

Scientific reports·2020

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Endogenous gamma-hydroxybutyric acid (GHB) functions as a neurotransmitter/neuromodulator in the central nervous system (CNS).
  • A distinct GHBergic system exists, involving specific synthesis, release, reuptake, and binding sites.
  • GHB is recognized as a recreational drug with abuse potential, leading to dependence and withdrawal.

Purpose of the Study:

  • To review the pharmacological profile of gamma-hydroxybutyric acid (GHB).
  • To examine the clinical and behavioral effects of GHB.
  • To update the understanding of GHB's role in the CNS and its therapeutic and adverse effects.

Main Methods:

  • Review of pharmacological, neurochemical, and electrophysiological studies.
  • Analysis of behavioral effects including sedation, seizures, and aggression.
  • Examination of clinical applications and potential neurotoxicity.

Main Results:

  • GHB acts as a neurotransmitter/neuromodulator, interacting with dopaminergic and GABAergic systems.
  • Behavioral effects include sedation, catalepsy, and potential seizure induction.
  • Clinical uses include treating narcolepsy and potential applications in substance abuse treatment.
  • Prolonged administration of GHB may lead to neurotoxic effects.

Conclusions:

  • GHB is a significant compound with neurotransmitter functions and therapeutic potential, notably for narcolepsy.
  • Its recreational abuse potential and risk of neurotoxicity present challenges for clinical application.
  • Further research is needed to balance GHB's benefits against its risks.

Related Experiment Videos